LeMaitre Vascular

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LMAT and other ETFs, options, and stocks.

About LMAT

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. 

CEO
George W. LeMaitre
CEOGeorge W. LeMaitre
Employees
655
Employees655
Headquarters
Burlington, Massachusetts
HeadquartersBurlington, Massachusetts
Founded
1983
Founded1983
Employees
655
Employees655

LMAT Key Statistics

Market cap
1.87B
Market cap1.87B
Price-Earnings ratio
29.39
Price-Earnings ratio29.39
Dividend yield
1.09%
Dividend yield1.09%
Average volume
597.99K
Average volume597.99K
High today
$84.35
High today$84.35
Low today
$81.31
Low today$81.31
Open price
$83.07
Open price$83.07
Volume
463.39K
Volume463.39K
52 Week high
$118.01
52 Week high$118.01
52 Week low
$78.65
52 Week low$78.65

Stock Snapshot

The current LeMaitre Vascular(LMAT) stock price is $81.52, with a market capitalization of 1.87B. The stock trades at a price-to-earnings (P/E) ratio of 29.39 and offers a dividend yield of 1.09%.

During the trading session on 2026-08-18, LeMaitre Vascular(LMAT) shares reached a daily high of $84.35 and a low of $81.31. At a current price of $81.52, the stock is +0.3% higher than the low and still -3.4% under the high.

Trading volume for LeMaitre Vascular(LMAT) stock has reached 463.39K, versus its average volume of 597.99K.

The stock's 52-week range extends from a low of $78.65 to a high of $118.01.

The stock's 52-week range extends from a low of $78.65 to a high of $118.01.

LMAT News

Simply Wall St 5d
How Investors May Respond To LeMaitre Vascular Trimmed 2026 Outlook Despite Higher Q2 Sales

LeMaitre Vascular, Inc. recently reported second-quarter 2026 results, with sales rising to US$70.38 million and net income to US$17.05 million, alongside confi...

How Investors May Respond To LeMaitre Vascular Trimmed 2026 Outlook Despite Higher Q2 Sales

Analyst ratings

50%

of 8 ratings
Buy
50%
Hold
50%
Sell
0%

People also own

Based on the portfolios of people who own LMAT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.